Avanos Medical AVNS
NYSE AVNS
$24.99 +0.01 (+0.04%)
At close: Jul 24, 2026 · 4:03 PM EDT

Avanos Medical (AVNS) Non-Current Debt (2013 - 2026)

Avanos Medical's (AVNS) quarterly Non-Current Debt came in at $87.3 million in Q1 2026, down 10.92% year-over-year from $98.0 million in Q1 2025, and down 3.32% quarter-over-quarter from $90.3 million in Q4 2025.

Analysis

Avanos Medical (AVNS) Non-Current Debt (2013 - 2026) Analysis & Trends

Avanos Medical has disclosed Non-Current Debt across 14 years of filings, most recently posting $87.3 million for Q1 2026.

  • In Q1 2026, Non-Current Debt fell 10.92% year-over-year to $87.3 million; the TTM figure through Mar 2026 stood at $87.3 million (down 10.92% YoY), while the FY2025 annual figure was $90.3 million, down 27.93% from the prior year.
  • Non-Current Debt came in at $87.3 million for Q1 2026 at Avanos Medical, down from $90.3 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $258.3 million in Q3 2023 to a low of $87.3 million in Q1 2026.
  • Average Non-Current Debt over 5 years is $169.3 million, with a median of $164.9 million recorded in 2024.
  • Year-over-year, Non-Current Debt jumped 74.08% in 2022 and sank 41.96% in 2025.
  • Over 5 years, Non-Current Debt stood at $226.3 million in 2022, then slipped by 29.56% to $159.4 million in 2023, then declined by 21.39% to $125.3 million in 2024, then decreased by 27.93% to $90.3 million in 2025, then slipped by 3.32% to $87.3 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $87.3 million in Q1 2026, $90.3 million in Q4 2025, and $93.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 29.60 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 25.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 14.19 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 10.92 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 598.70 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -1.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 1.65 Bn
10 Avanos Medical 1.17 Bn 1.10 Bn 94.20 Mn 87.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 87.30 Mn
Dec 31, 2025 90.30 Mn
Sep 30, 2025 93.40 Mn
Jun 30, 2025 95.70 Mn
Mar 31, 2025 98.00 Mn
Dec 31, 2024 125.30 Mn
Sep 30, 2024 152.60 Mn
Jun 30, 2024 164.90 Mn
Mar 31, 2024 167.20 Mn
Dec 31, 2023 159.40 Mn
Sep 30, 2023 258.30 Mn
Jun 30, 2023 203.30 Mn
Mar 31, 2023 204.70 Mn
Dec 31, 2022 226.30 Mn
Sep 30, 2022 247.80 Mn
Jun 30, 2022 249.30 Mn
Mar 31, 2022 254.40 Mn
Dec 31, 2021 130.00 Mn
Sep 30, 2021 145.00 Mn
Jun 30, 2021 165.00 Mn